BCL2 and uveal melanoma: Altogether Bax expression was not altered, the down-regulation of Bcl-2 expression and the decreased ratio of Bcl-2/Bax might be mechanistically responsible for the reduced uveal melanoma cell survival following BAY11-7082 treatment.